Timo Soeterik

154 CHAPTER 8 SUPPLEMENTARY TABLE S3. Systematic analysis of MSKCC 2018 for nomogram-derived cut-offs MSKCC 2018 Threshold (%) DRE T-stage mpMRI T-stage Patients in whom ePLND is not / is recommended (%) Patients below cut- off without / with LNI (%) Patients above cut-off without / with LNI (%) ePLND spared (%) LNI missed (%) Patients in whom ePLND is not / is recommended (%) Patients below cut-off without / with LNI (%) Patients above cut-off without/with LNI (%) ePLND spared (%) LNI missed (%) 1 5 (0.05) / 1057 (99.5) 3 (60) / 2 (40) 758 (72) / 299 (28) 5 (0.05) 2 (0.2) 0 (0) / 1062 (100) 0 (0) / 0 (0) 761 (72) / 301 (28) 0 (0) 0 (0) 2 33 (3.1) / 1029 (96.9) 31 (94) / 2 (6.1) 730 (71) / 299 (29) 33 (3.1) 2 (0.2) 9 (0.8) / 1053 (99.2) 8 (89) / 1 (11) 753 (71) / 300 (29) 9 (0.9) 1 (0.1) 3 56 (5.4) / 985 (95) 50 (89) / 6 (11) 711 (71) / 295 (29) 56 (5.3) 6 (0.6) 31 (3.0) / 1031 (97) 28 (90) / 3 (10) 733(71) / 298 (29) 31 (2.9) 3 (0.3) 4 87 (8.3) / 955 (92) 77 (89) / 10 (11) 684 (70) / 291 (30) 87 (8.2) 10 (1.0) 51 (4.9) / 1011 (95) 46 (90) / 5 (10) 715 (71) / 296 (29) 51 (4.8) 5 (0.5) 5 114 (11) / 948 (89) 101 (89) / 13 (11) 660 (70) / 288 (30) 114 (11) 13 (1.2) 63 (6.1) / 999 (93.9) 56 (89) / 7 (11) 705 (71) / 294 (29) 63 (5.9) 7 (0.7) 6 143 (13) / 919 (87) 126 (88) / 17 (12) 635 (69) / 284 (31) 143 (13) 17 (1.6) 80 (7.5) / 982 (92.5) 72 (90) / 8 (10) 689 (70) / 293 (30) 80 (7.5) 8 (0.8) 7 184 (17) / 878 (83) 159 (86) / 25 (14) 602 (69) / 276 (31) 184 (17) 25 (2.3) 102 (9.7) / 960 (90.3) 93 (91) / 9 (9) 668 (70) / 292 (30) 102 (9.6) 9 (0.8) 8 225 (21) / 822 (79) 195 (87) / 30 (13) 566 (68) / 271 (32) 225 (21) 30 (2.8) 129 (10) / 933 (90) 116 (90) / 13 (10) 645 (69) / 288 (31) 129 (12.1) 13 (1.2) 9 259 (24) / 788 (75) 223 (86) / 36 (14) 538 (67) / 265 (33) 259 (24) 36 (3.4) 146 (14) / 916 (86) 132 (90) / 14 (10) 629 (69) / 287 (31) 146 (14) 14 (1.3)